Chinese trade negotiators suddenly canceled a visit to meet U.S. farmers after they wrapped up trade talks in Washington this week.Marketsread more
Trump also said he is "not looking for a partial deal" with Beijing, moving away from his suggestion last week that he would consider an "interim deal."Politicsread more
For investors taking a breather from the chaos in August, buckle up as the market is about go crazy again, Goldman Sachs warned.Marketsread more
Canadian trade union Unifor said roughly 4,500 of its members have been temporarily laid off because of the GM strike so far.Autosread more
"I really want to encourage competition because I think competition creates innovation, and when you create innovation everyone wins," Humana CEO Bruce Broussard says.Health and Scienceread more
The former top aide of retired United Auto Workers Vice President Joe Ashton, a former member of the GM's board, was charged Friday with conspiracy to commit wire fraud and...Autosread more
Stocks fell to their lows of the day on Friday on news that Chinese trade officials are cutting short their visit to the U.S.US Marketsread more
The wearables company has reportedly retained advisers to consider exploring a sale of the business.Technologyread more
Roku shares have more than quadrupled this year, but the stock has had some rocky days of late as more players jump into streaming.Technologyread more
Walmart is the latest to pull back from the industry. Federal regulators said they will soon ban flavored e-cigarettes, while some nations have outlawed the products...Health and Scienceread more
Legal experts say that California, which has pledged to sue, has a strong case that the administration's move is unlawful.Politicsread more
Oxford University will be at the forefront of a multimillion-pound research program, which hopes to help develop new therapies for acute and chronic conditions by examining the effects of medical cannabis.
The oldest university in England will be teaming up with private equity company, Kingsley Capital Partners who will provide up to £10 million ($12.36 million) in initial investment, which will be funded through its new biopharmaceutical firm Oxford Cannabinoid Technologies (OCT).
The partnership is expected to bring together Kingsley's financial backing and Oxford's clinical expertise and research in immunology, neuroscience and cancer, to find ways of developing new treatments for those suffering with pain, cancer and inflammatory disease.
Scientists at the university expect to do this by studying the cellular, molecular, and systems mechanisms of cannabinoids.
"Cannabinoid research has started to produce exciting biological discoveries and this research program is a timely opportunity to increase our understanding of the role of cannabinoids in health and disease," Ahmed Ahmed, professor of gynaecological oncology at Oxford University, said in a statement.
While medical cannabis and cannabinoid medicine has been seen as providing support to patients who've been in pain; research into the particular pathways and mechanisms that produce this benefit is currently "limited and long overdue", Neil Mahapatra, managing partner at Kingsley Capital Partners, explained.
"Through OCT, we hope our strategic partnership with Oxford will support the development of innovative new therapies to help millions of people around the world," he added.
The project has even received a public endorsement from Star Trek and X-Men actor Patrick Stewart, who admitted in a statement to using cannabis-based products to help the ortho-arthritis in his hands – a recommendation provided by a doctor in Los Angeles two years ago.
At present, cannabis is not permitted in the U.K. despite calls for its legislation, however, the cannabis-based ingredient, cannabidiol has recently been classified as a medicine. In 2016, a cross-party group of U.K. politicians called upon the government to legalize medical cannabis, stating that there was a sound evidence base that revealed cannabis could be effective for a number of chronic conditions.
"I enthusiastically support the Oxford University Cannabis Research Plan. This is an important step forward for Britain in a field of research that has for too long been held back by prejudice, fear and ignorance," Actor Patrick Stewart said in a statement, emailed to CNBC.
"I believe this program of research might result in benefits for people like myself as well as millions of others."